ctrl K

Kiromic BioPharma Inc. (KRBP)

OTC: KRBP · Real-Time Price · USD

0.20

0.00 (0.05%)

At close: Mar 24, 2025, 3:59 PM

Kiromic BioPharma Income Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018
Revenue	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Cost of Revenue	n/a	2.8M	2.07M	469.8K	200K	87.5K	80.9K
Gross Profit	n/a	-2.8M	-2.07M	-469.8K	-200K	-87.5K	-80.9K
Operating Income	-23.77M	-19.94M	-31.11M	-25.74M	-19.2M	-3.71M	-3.18M
Interest Income	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Pretax Income	-26.9M	-20.95M	-34.73M	-25.59M	-19.2M	-3.73M	-3.82M
Net Income	-26.9M	-21.29M	-38.18M	-25.65M	-19.2M	-3.75M	-3.82M
Selling & General & Admin	8.85M	7.52M	17.19M	13.94M	14.14M	2.5M	1.76M
Research & Development	6.85M	9.62M	13.92M	11.37M	5.05M	1.2M	1.42M
Other Expenses	8.07M	n/a	n/a	53.4K	n/a	n/a	n/a
Operating Expenses	23.77M	17.14M	31.11M	25.31M	19.2M	3.71M	3.18M
Interest Expense	-3.72M	-1.85M	166.5K	12.2K	3.3K	22.5K	633.1K
Selling & Marketing Expenses	n/a	-2.8M	n/a	n/a	n/a	n/a	n/a
Cost & Expenses	n/a	19.94M	31.11M	25.31M	19.2M	3.71M	3.18M
Income Tax Expense	n/a	n/a	3.45M	65.6K	3.3K	22.5K	-80.24K
Shares Outstanding (Basic)	26.07M	32.93M	16.34M	11.42M	7.28M	3.88M	3.53M
Shares Outstanding (Diluted)	26.07M	32.93M	16.34M	11.42M	7.28M	3.88M	3.53M
EPS (Basic)	-1.03	-21.41	-70.12	-67.4	-79.08	-29	-32.4
EPS (Diluted)	-1.03	-21.41	-70.12	-67.4	-79.08	-29	-32.4
EBITDA	-23.77M	-16.3M	-32.5M	-25.74M	-19M	-3.62M	-3.1M
EBIT	-30.62M	-19.1M	-34.56M	-25.58M	-19.2M	-3.71M	-3.18M
Depreciation & Amortization	n/a	2.8M	2.07M	469.8K	200K	87.5K	80.9K